| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/04/1999 | WO1999010016A1 Combinatorial library |
| 03/04/1999 | WO1999010015A2 Method for producing contrast agents largely free of side-effects |
| 03/04/1999 | DE19737409A1 Diagnosekit für Hauttest und Verfahren zur Durchführung desselben Same diagnostic kit for skin test and procedures for implementing |
| 03/04/1999 | CA2341969A1 Combinatorial library |
| 03/03/1999 | EP0898970A1 Diagnostic agent for digestive diseases |
| 03/03/1999 | EP0898574A1 Fluorescent chelates as visual tissue specific imaging agents |
| 03/03/1999 | EP0888129A4 Magnetic resonance blood pool agents bound to human serum albumin |
| 03/03/1999 | EP0820462B1 Hydrolysis and photocleavage of nucleic acid using a metal complex |
| 03/03/1999 | EP0537276B1 Cancer-associated scm-recognition factor, preparation and method of use |
| 03/03/1999 | CN1209754A Perfluoroalkyl-containing metal complexes, its preparing method and use in NMR diagnostics |
| 03/03/1999 | CN1209753A Non-invasive localization of light-emitting conjugate in mammal animal |
| 03/03/1999 | CN1209751A Improved concentrated injection and infusion solutions for intravenous administration |
| 03/02/1999 | US5877399 Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
| 03/02/1999 | US5877305 DNA encoding biosynthetic binding protein for cancer marker |
| 03/02/1999 | US5877289 Tissue factor compositions and ligands for the specific coagulation of vasculature |
| 03/02/1999 | US5876698 Contrast agent for magnetic resonance imaging |
| 03/02/1999 | US5876697 Microbubble ultrasonic contrast agent with long life internal stability properties |
| 03/02/1999 | US5876696 Composition comprising a fluorine containing surfactant and perfluoropentane for ultrasound |
| 03/02/1999 | US5876695 Nuclear magnetic resonance contrast agent |
| 03/02/1999 | US5876694 Azavesamicols |
| 03/02/1999 | US5876691 Screening a bacteriophage library; diagnosis of colorectal tumors |
| 02/25/1999 | WO1999009412A1 Functional fragments of hiv-1 vpr protein and methods of using the same |
| 02/25/1999 | WO1999008941A1 Sol-gel coated polarization vessels |
| 02/25/1999 | WO1999008782A1 Process for preparation of vesicles |
| 02/25/1999 | WO1999008716A2 Process for preparation of lyophilised contrast agents |
| 02/25/1999 | WO1999008715A1 Process for preparing contrast agents |
| 02/25/1999 | WO1999008714A1 Improvements in or relating to contrast agents |
| 02/25/1999 | CA2301295A1 Functional fragments of hiv-1 vpr protein and methods of using the same |
| 02/24/1999 | EP0897922A2 Cocaine receptor binding ligands |
| 02/23/1999 | US5874573 Cyclic amine derivatives |
| 02/23/1999 | US5874542 Single chain antibodies specific to VEGF receptors |
| 02/23/1999 | US5874422 Reducing the drug side-effect while treating cardiovascular system disorder |
| 02/23/1999 | US5874305 Androgen-repressed metastatic human prostate cancer cell line |
| 02/23/1999 | US5874062 Medical diagnosis with fluorocarbons in microspheres |
| 02/23/1999 | US5874061 Paramagnetic contrast agents for both nuclear spin and computor tomography and magnetic resonance imaging; marking vascular space (blood-pool agents); biocompatibility; high signal intensity, therefore a lower dosage used |
| 02/23/1999 | CA1340409C Functionally specific antibodies |
| 02/18/1999 | WO1999007415A1 Administrable compositions and methods for magnetic resonance imaging |
| 02/18/1999 | WO1999007325A1 Liver function test |
| 02/17/1999 | EP0896655A1 High volume hyperpolarizer for spin-polarized noble gas |
| 02/17/1999 | EP0896547A1 Diagnostic composition |
| 02/17/1999 | EP0896546A2 Method of t1-weighted magnetic resonance imaging of res organs |
| 02/17/1999 | CN1208353A Contrast media |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872107 Anticarcinogenic agents capture therapy for tumors |
| 02/16/1999 | US5871709 Tetraazacyclododecane compounds substituted with alkyl carboxy compounds for cardiovascular disorders and brain tumors |
| 02/16/1999 | CA2000112C Iron containing preparation for nmr imaging and nmr imaging method using the same |
| 02/11/1999 | WO1999006411A1 Metallation of macrocycles with 2,4-dicarbonyl-metal complexes |
| 02/11/1999 | WO1999006074A1 Use of texaphyrins in detection of melanin and melanin metabolites of melanotic melanoma |
| 02/11/1999 | WO1998048844A3 Ion paris, method for the production and use thereof as contrast agents |
| 02/11/1999 | CA2299434A1 Metallation of macrocycles with 2,4-dicarbonyl-metal complexes |
| 02/11/1999 | CA2296572A1 Contrast agent-enhanced magnetic resonance imaging of tissue perfusion |
| 02/10/1999 | CN1207685A Novel medical use of ACE-inhibitor for treatment of dyspeptic symptoms |
| 02/09/1999 | US5869638 Bone-related cadherin-like protein and process for its production |
| 02/09/1999 | US5869616 Imaging agent composed of n-terminal amino acid sequence of fibronectin and label; for noninvasive, accurate diagnosis of a thrombus or atherosclerotic plaque |
| 02/09/1999 | US5869045 Polypeptide comprising antigen-binding region of monoclonal antibody produced by specified hybridoma |
| 02/09/1999 | US5869026 Tripodal carboxamide ligands for MRI contrast agents |
| 02/09/1999 | US5869025 Stable complexes with good relaxivity and osmolar characteristics; lower dosages, lower toxicity, higher resolution, more specificity |
| 02/09/1999 | US5869024 Methods and compositions for using non-ionic contrast agents to reduce the risk of clot formation in diagnostic procedures |
| 02/09/1999 | US5869023 Composition for MRI comprising both a positive and a negative contrast agent |
| 02/09/1999 | CA2069638C Mri image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands |
| 02/04/1999 | WO1999005521A2 Conjugate for differentiating between healthy and unhealthy tissue |
| 02/04/1999 | WO1999005145A1 1,4,7,10-tetraazabicyclo[8.2.2]tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles |
| 02/04/1999 | WO1999004827A1 Method for detection of fibrin clots |
| 02/04/1999 | WO1999004826A1 Method for detection of fibrin clots |
| 02/04/1999 | WO1998050081A3 In vivo expression system for cellular receptors |
| 02/04/1999 | DE19729013A1 Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik Oligomers, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnosis |
| 02/03/1999 | EP0894807A1 GPIb-LIPID COMPLEX AND USES THEREOF |
| 02/02/1999 | US5866760 Stat6 deficient transgenic mice |
| 02/02/1999 | US5866756 Dopamine transporter knockout mice |
| 02/02/1999 | US5866719 Process for the purification of an aminoalcohol |
| 02/02/1999 | US5866679 Peptides |
| 02/02/1999 | US5866570 Treatment of vascular leakage and related syndrome such as septic shock by administration of metalloproteinase inhibitors |
| 02/02/1999 | US5866372 Investigation and diagnosis of anaplastic large-cell lymphomas. |
| 02/02/1999 | US5866100 Compositions for imaging of the gastrointestinal tract |
| 02/02/1999 | US5866099 Magnetic-polymer particles |
| 01/28/1999 | WO1999003558A1 Process for the selection of particles of a preselected size from a particulate pharmaceutical product |
| 01/28/1999 | WO1999003510A1 Diagnostics for complications of diabetes or renal insufficiency |
| 01/28/1999 | WO1998046275A3 Blood-pool carrier for lipophilic imaging agents |
| 01/28/1999 | DE19731741A1 Konjugat zur Unterscheidung von krankhaftem und gesundem Gewebe Conjugate to distinguish between diseased and healthy tissue |
| 01/27/1999 | EP0892645A2 Activatable infusable dispersions and methods for using them for therapy and diagnostics |
| 01/27/1999 | EP0367787B2 Method for enhancing the safety of metal-ligand chelates as x-ray contrast agents |
| 01/26/1999 | US5863538 Compositions for targeting the vasculature of solid tumors |
| 01/26/1999 | US5863520 Images for medical diagnosis of organs |
| 01/26/1999 | US5863519 A first contrast agent comprising a magnesium compound and organic-acid absorption promoter and a second contrast agent having an opposing contrast effect; imaging gastrointestinal tract, particularly the liver; heart side-effects reduced |
| 01/26/1999 | US5863518 Diagnostic imaging agent with backbone with modified sugar chain end |
| 01/21/1999 | WO1999002651A1 Optical fiberless sensors |
| 01/21/1999 | WO1999002538A1 Novel chelating ligands having a tripodal backbone |
| 01/21/1999 | WO1999002193A2 Triiodine aromates containing perfluoroalkyl groups, method for the production and use thereof as contrast agents |
| 01/21/1999 | WO1999002178A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 01/21/1999 | WO1999002120A2 Compositions and methods for reversibly increasing permeability of biomembranes |
| 01/21/1999 | WO1998047538A3 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 01/21/1999 | DE19731300C1 Perfluoralkylgruppenhaltige Trijodaromaten, Verfahren zu deren Herstellung und deren Verwendung als Kontrastmittel Perfluoroalkyl Trijodaromaten, to processes for their preparation and their use as contrast agents |
| 01/21/1999 | DE19730923A1 X=ray contrast composition for direct lung visualisation |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0637310B1 Water-soluble retinoids |
| 01/19/1999 | US5861156 Methods of delivering agents to target cells |
| 01/19/1999 | US5861140 Tripodal paramagnetic contrast agents for MR imaging |
| 01/19/1999 | US5861138 Ligands for MRI contrast agent |
| 01/19/1999 | US5860295 Cryogenic accumulator for spin-polarized xenon-129 |
| 01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |